Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback